Abstract
The pituitary gonadotropin response to the administration of synthetic LH releasing hormone (LH RH) in 10 patients with renal failure and 5 patients with hepatic insufficiency was determined. The basal plasma LH and FSH levels were either normal or slightly elevated in both groups compared with the controls, but after the administration of LH RH, the peak levels (mean ± (SE) mIU/ml) of LH (72.0 ± 16.6) and FSH (18.7 ± 4.4) in the patients with renal failure, and of LH (61.5 ± 20.8) and FSH (13.2 ± 2.8) in patients with hepatic insufficiency, were not significantly different from those in 11 normal controls (LH, 75.6 ± 12.0; FSH, 12.4 ± 2.9). However, significant elevations in plasma gonadotropin levels persisted in these patients during the second and third hours after the administration of LH RH. These studies do not resolve the question of whether the prolonged elevation in plasma LH and FSH levels after LH RH administration is due to enhanced secretion, to a diminished rate of metabolic clearance of LH RH, and/or to the gonadotropins, or both. Evidence from this and previous studies suggest that there may be defects in the secretory functions of both the hypothalamus and pituitary gland in some of these patients.
| Original language | English |
|---|---|
| Pages (from-to) | 921-925 |
| Number of pages | 5 |
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Volume | 41 |
| Issue number | 5 |
| State | Published - Dec 1 1975 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Biochemistry
- Endocrinology, Diabetes and Metabolism
Cite this
Plasma gonadotropins after administration of LH releasing hormone in patients with renal or hepatic failure. / Schalch, D. S.; Gonzalez-Barcena, D.; Kastin, A. J.; Landa, L.; Lee, L. A.; Zamora, M. T.; Schally, Andrew V.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 41, No. 5, 01.12.1975, p. 921-925.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Plasma gonadotropins after administration of LH releasing hormone in patients with renal or hepatic failure
AU - Schalch, D. S.
AU - Gonzalez-Barcena, D.
AU - Kastin, A. J.
AU - Landa, L.
AU - Lee, L. A.
AU - Zamora, M. T.
AU - Schally, Andrew V
PY - 1975/12/1
Y1 - 1975/12/1
N2 - The pituitary gonadotropin response to the administration of synthetic LH releasing hormone (LH RH) in 10 patients with renal failure and 5 patients with hepatic insufficiency was determined. The basal plasma LH and FSH levels were either normal or slightly elevated in both groups compared with the controls, but after the administration of LH RH, the peak levels (mean ± (SE) mIU/ml) of LH (72.0 ± 16.6) and FSH (18.7 ± 4.4) in the patients with renal failure, and of LH (61.5 ± 20.8) and FSH (13.2 ± 2.8) in patients with hepatic insufficiency, were not significantly different from those in 11 normal controls (LH, 75.6 ± 12.0; FSH, 12.4 ± 2.9). However, significant elevations in plasma gonadotropin levels persisted in these patients during the second and third hours after the administration of LH RH. These studies do not resolve the question of whether the prolonged elevation in plasma LH and FSH levels after LH RH administration is due to enhanced secretion, to a diminished rate of metabolic clearance of LH RH, and/or to the gonadotropins, or both. Evidence from this and previous studies suggest that there may be defects in the secretory functions of both the hypothalamus and pituitary gland in some of these patients.
AB - The pituitary gonadotropin response to the administration of synthetic LH releasing hormone (LH RH) in 10 patients with renal failure and 5 patients with hepatic insufficiency was determined. The basal plasma LH and FSH levels were either normal or slightly elevated in both groups compared with the controls, but after the administration of LH RH, the peak levels (mean ± (SE) mIU/ml) of LH (72.0 ± 16.6) and FSH (18.7 ± 4.4) in the patients with renal failure, and of LH (61.5 ± 20.8) and FSH (13.2 ± 2.8) in patients with hepatic insufficiency, were not significantly different from those in 11 normal controls (LH, 75.6 ± 12.0; FSH, 12.4 ± 2.9). However, significant elevations in plasma gonadotropin levels persisted in these patients during the second and third hours after the administration of LH RH. These studies do not resolve the question of whether the prolonged elevation in plasma LH and FSH levels after LH RH administration is due to enhanced secretion, to a diminished rate of metabolic clearance of LH RH, and/or to the gonadotropins, or both. Evidence from this and previous studies suggest that there may be defects in the secretory functions of both the hypothalamus and pituitary gland in some of these patients.
UR - http://www.scopus.com/inward/record.url?scp=0016814048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016814048&partnerID=8YFLogxK
M3 - Article
C2 - 1102555
AN - SCOPUS:0016814048
VL - 41
SP - 921
EP - 925
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 5
ER -